Beyond clinical phenotype: The biologic integratome

Critical Care Medicine

Volumn 37, Issue SUPPL. 1, 2009, Pages

  Grimaldi, David ^a   Claessens, Yann Erick ^b   Mira, Jean Paul ^a,b   Chiche, Jean Daniel ^a,b  

^a University Paris Descartes ^*  (France)

^b INSTITUT COCHIN   (France)

Author keywords

Biological models; Cell physiology; Computational biology; Drug effect; Genomics; Metabolic networks and pathways; Network analysis; Proteomics; Signal transduction

Indexed keywords

CELL FUNCTION; CRITICALLY ILL PATIENT; DRUG EFFECT; DRUG MECHANISM; ENVIRONMENTAL FACTOR; GENE EXPRESSION; GENE SEQUENCE; GENOME; GENOMICS; LIPIDOMICS; MEDICAL RESEARCH; METABOLOMICS; PATH ANALYSIS; PATHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS; ARTICLE; BIOLOGY; CRITICAL ILLNESS; DRUG DESIGN; ENVIRONMENT; GENE EXPRESSION PROFILING; HUMAN; METABOLISM;

DNA; PROTEIN;

COMPUTATIONAL BIOLOGY; CRITICAL ILLNESS; DNA; DRUG DESIGN; ENVIRONMENT; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; METABOLOMICS; PHENOTYPE; PROTEINS;

EID: 58849100935     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181920cca     Document Type: Article

References (63)

1. Kellis M, Patterson N, Endrizzi M, et al: Sequencing and comparison of yeast species to identify genes and regulatory elements. Nature 2003; 423:241-254
2. Chimpanzee Sequencing and Analysis Consortium: Initial sequence of the chimpanzee genome and comparison with the human genome. Nature 2005; 437:69-87
3. Delsuc F, Brinkmann H, Philippe H: Phylogenomics and the reconstruction of the tree of life. Nat Rev Genet 2005; 6:361-375
4. Tompa M, Li N, Bailey TL, et al: Assessing computational tools for the discovery of transcription factor binding sites. Nat Biotechnol 2005; 23:137-144
5. Brasch MA, Hartley JL, Vidal M: ORFeome cloning and systems biology: Standardized mass production of the parts from the partslist. Genome Res 2004; 14:2001-2009
6. Irizarry RA, Warren D, Spencer F, et al: Multiple-laboratory comparison of microarray platforms. Nat Methods 2005; 2:345-350
7. Harbers M, Carninci P: Tag-based approaches for transcriptome research and genome annotation. Nat Methods 2005; 2:495-502
8. Jenner RG, Young RA: Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol 2005; 3:281-294
9. Rhodes DR, Chinnaiyan AM: Integrative analysis of the cancer transcriptome. Nat Genet 2005; 37(Suppl):S31-S37
10. Mata J, Marguerat S, Bahler J: Posttranscriptional control of gene expression: A genome-wide perspective. Trends Biochem Sci 2005; 30:506-514
11. Cho WC: Proteomics technologies and challenges. Genomics Proteomics Bioinformatics 2007; 5:77-85
12. Gevaert K, Van Damme P, Ghesquiere B, et al: A la carte proteomics with an emphasis on gel-free techniques. Proteomics 2007; 7:2698-2718
13. Kuster B, Schirle M, Mallick P, et al: Scoring proteomes with proteotypic peptide probes. Nat Rev Mol Cell Biol 2005; 6:577-583
14. Hollywood K, Brison DR, Goodacre R: Metabolomics: Current technologies and future trends. Proteomics 2006; 6:4716-4723
15. Markuszewski MJ, Szczykowska M, Siluk D, et al: Human red blood cells targeted metabolome analysis of glycolysis cycle metabolites by capillary electrophoresis using an indirect photometric detection method. J Pharm Biomed Anal 2005; 39:636-642
16. Mashego MR, Rumbold K, De Mey M, et al: Microbial metabolomics: Past, present and future methodologies. Biotechnol Lett 2007; 29:1-16
17. Robertson DG: Metabonomics in toxicology: A review. Toxicol Sci 2005; 85:809-822
18. Robertson DG, Reily MD, Baker JD: Metabonomics in preclinical drug development. Expert Opin Drug Metab Toxicol 2005; 1:363-376
19. Kell DB: Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discov Today 2006; 11: 1085-1092
20. Jordan KW, Cheng LL: NMR-based metabolomics approach to target biomarkers for human prostate cancer. Expert Rev Proteomics 2007; 4:389-400
21. Mayr M, Madhu B, Xu Q: Proteomics and metabolomics combined in cardiovascular research. Trends Cardiovasc Med 2007; 17: 43-48
22. Pendyala G, Want EJ, Webb W, et al: Biomarkers for neuroAIDS: The widening scope of metabolomics. J Neuroimmune Pharmacol 2007; 2:72-80
23. Gibney MJ, Walsh M, Brennan L, et al: Metabolomics in human nutrition: Opportunities and challenges. Am J Clin Nutr 2005; 82:497-503
24. Huh WK, Falvo JV, Gerke LC, et al: Global analysis of protein localization in budding yeast. Nature 2003; 425:686-691
25. Guda C, Subramaniam S: pTARGET [corrected] a new method for predicting protein subcellular localization in eukaryotes. Bioinformatics 2005; 21:3963-3969
26. Harbison CT, Gordon DB, Lee TI, et al: Tran-scriptional regulatory code of a eukaryotic genome. Nature 2004; 431:99-104
27. Pokholok DK, Harbison CT, Levine S, et al: Genome-wide map of nucleosome acetylation and methylation in yeast. Cell 2005; 122:517-527
28. Kim TH, Barrera LO, Zheng M, et al: A highresolution map of active promoters in the human genome. Nature 2005; 436:876-880
29. Cawley S, Bekiranov S, Ng HH, et al: Unbiased mapping of transcription factor binding sites along human chromosomes 21 and 22 points to widespread regulation of noncoding RNAs. Cell 2004; 116:499-509
30. Martone R, Euskirchen G, Bertone P, et al: Distribution of NF-kappaB-binding sites across human chromosome 22. Proc Natl Acad Sci USA 2003; 100:12247-12252
31. Zhang X, Odom DT, Koo SH, et al: Genomewide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 2005; 102: 4459-4464
32. Formstecher E, Aresta S, Collura V, et al: Protein interaction mapping: A Drosophila case study. Genome Res 2005; 15:376-384
33. Li S, Armstrong CM, Bertin N, et al: A map of the interactome network of the metazoan C. elegans. Science 2004; 303:540-543
34. Rual JF, Venkatesan K, Hao T, et al: Towards a proteome-scale map of the human proteinprotein interaction network. Nature 2005; 437:1173-1178
35. Stelzl U, Worm U, Lalowski M, et al: A human protein-protein interaction network: A resource for annotating the proteome. Cell 2005; 122:957-968
36. Dykxhoorn DM, Lieberman J: The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med 2005; 56:401-423
37. Bredel M, Jacoby E: Chemogenomics: An emerging strategy for rapid target and drug discovery. Nat Rev Genet 2004; 5:262-275
38. Barabasi AL, Oltvai ZN: Network biology: Understanding the cell's functional organization. Nat Rev Genet 2004; 5:101-113
39. Joyce AR, Palsson BO: The model organism as a system: integrating "omics" data sets. Nat Rev Mol Cell Biol 2006; 7:198-210
40. Hall P, Ploner A, Bjohle J, et al: Hormonere-placement therapy influences gene expression profiles and is associated with breast-cancer prognosis: A cohort study. BMC Med 2006; 4:16
41. Wang Y, Klijn JG, Zhang Y, et al: Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005; 365:671-679
42. Sebastiani P, Ramoni MF, Nolan V, et al: Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat Genet 2005; 37:435-440
43. Pastor-Satorras R, Vespignani A: Epidemic dynamics and endemic states in complex networks. Phys Rev E Stat Nonlin Soft Matter Phys 2001; 63(6 Pt 2):066117
44. Pastor-Satorras R, Vespignani A: Immunization of complex networks. Phys Rev E Stat Nonlin Soft Matter Phys 2002; 65(3 Pt 2A): 036104
45. Ergun A, Lawrence CA, Kohanski MA, et al: A network biology approach to prostate cancer. Mol Syst Biol 2007; 3:82
46. Pujana MA, Han JD, Starita LM, et al: Network modeling links breast cancer susceptibility and centrosome dysfunction. Nat Genet 2007; 39:1338-1349
47. Lu X, Jain VV, Finn PW, et al: Hubs in biological interaction networks exhibit low changes in expression in experimental asthma. Mol Syst Biol 2007; 3:98
48. King JY, Ferrara R, Tabibiazar R, et al: Pathway analysis of coronary atherosclerosis. Physiol Genomics 2005; 23:103-118
49. Calvano SE, Xiao W, Richards DR, et al: A network-based analysis of systemic inflammation in humans. Nature 2005; 437: 1032-1037
50. Talwar S, Munson PJ, Barb J, et al: Gene expression profiles of peripheral blood leukocytes after endotoxin challenge in humans. Physiol Genomics 2006; 25:203-215
51. Tegner J, Nilsson R, Bajic VB, et al: Systems biology of innate immunity. Cell Immunol 2006; 244:105-109
52. Gonye GE, Chakravarthula P, Schwaber JS, et al: From promoter analysis to transcriptional regulatory network prediction using PAINT. Methods Mol Biol 2007; 408:49-68
53. Johnson DS, Mortazavi A, Myers RM, et al: Genome-wide mapping of in vivo protein-DNA interactions. Science 2007; 316: 1497-1502
54. Ma H, Sorokin A, Mazein A, et al: The Edinburgh human metabolic network reconstruction and its functional analysis. Mol Syst Biol 2007; 3:135
55. Duarte NC, Becker SA, Jamshidi N, et al: Global reconstruction of the human metabolic network based on genomic and bibliomic data. Proc Natl Acad Sci USA 2007; 104:1777-1782
56. Lim J, Hao T, Shaw C, et al: A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 2006; 125:801-814
57. Goh KI, Cusick ME, Valle D, et al: The human disease network. Proc Natl Acad Sci USA 2007; 104:8685-8690
58. Kitano H: A robustness-based approach to systems-oriented drug design. Nat Rev Drug Discov 2007; 6:202-210
59. Hopkins AL: Network pharmacology. Nat Biotechnol 2007; 25:1110-1111
60. Nicholson JK: Global systems biology, personalized medicine and molecular epidemiology. Mol Syst Biol 2006; 2:52
61. Paolini GV, Shapland RH, van Hoorn WP, et al: Global mapping of pharmacological space. Nat Biotechnol 2006; 24:805-815
62. Yildirim MA, Goh KI, Cusick ME, et al: Drugtarget network. Nat Biotechnol 2007; 25: 1119-1126
63. Keiser MJ, Roth BL, Armbruster BN, et al: Relating protein pharmacology by ligand chemistry. Nat Biotechnol 2007; 25:197-206